7,686
Views
93
CrossRef citations to date
0
Altmetric
Letter

Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae

, , , , , , , , , , , , , ORCID Icon, , , , , , , & ORCID Icon show all
Pages 771-774 | Received 01 Feb 2020, Accepted 23 Mar 2020, Published online: 02 Apr 2020

References

  • Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41(3):281–288. doi: 10.1086/431587
  • Hollyer I, Ison MG. The challenge of urinary tract infections in renal transplant recipients. Transpl Infect Dis. 2018;20(2):e12828. doi: 10.1111/tid.12828
  • Wyres KL, Lam MMC, Holt KE. Population genomics of Klebsiella pneumoniae. Nat Rev Microbiol. 2020 Feb 13. doi:10.1038/s41579-019-0315-1 [Epub ahead of print].
  • Kortright KE, Chan BK, Koff JL, et al. Phage therapy: a renewed approach to Combat antibiotic-resistant bacteria. Cell Host Microbe. 2019;25(2):219–232. doi: 10.1016/j.chom.2019.01.014
  • Sybesma W, Zbinden R, Chanishvili N, et al. Bacteriophages as potential treatment for urinary tract infections. Front Microbiol. 2016;7:465. doi: 10.3389/fmicb.2016.00465
  • Jault P, Leclerc T, Jennes S, et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis. 2018;19(1):35–45. doi: 10.1016/S1473-3099(18)30482-1
  • Dedrick RM, Guerrero-Bustamante CA, Garlena RA, et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med. 2019;25(5):730–733. doi: 10.1038/s41591-019-0437-z
  • Azam AH, Tanji Y. Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy. Appl Microbiol Biotechnol. 2019;103(5):2121–2131. doi: 10.1007/s00253-019-09629-x
  • Rohde C, et al. Expert opinion on three phage therapy Related Topics: bacterial phage resistance, phage training and Prophages in bacterial Production strains. Viruses. 2018 Apr 5;10(4):178. doi: 10.3390/v10040178
  • Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International clinical Practice Guidelines from the infectious Diseases society of America. Clin Infect Dis. 2010;50(5):625–663. doi: 10.1086/650482
  • Shen M, Zhang H, Shen W, et al. Pseudomonas aeruginosa MutL promotes large chromosomal deletions through non-homologous end joining to prevent bacteriophage predation. Nucleic Acids Res. 2018;46(9):4505–4514. doi: 10.1093/nar/gky160
  • Roach DR, et al. Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute Respiratory pathogen. Cell Host Microbe. 2017;22(1):38–47.e4. doi: 10.1016/j.chom.2017.06.018
  • Kuipers S, et al. A Dutch case report of successful treatment of chronic relapsing urinary tract infection with bacteriophages in a renal transplant patient. Antimicrob Agents Chemother. 2019 2019 Dec 20;64(1). pii: e01281–19. doi:10.1128/AAC.01281-19.
  • Yang Y, Shen W, Zhong Q, et al. Development of a bacteriophage cocktail to constrain the emergence of phage-resistant Pseudomonas aeruginosa. Front Microbiol. 2020;11:327. doi: 10.3389/fmicb.2020.00327
  • Hesse S, Rajaure M, Wall E, et al. Phage resistance in multidrug-resistant Klebsiella pneumoniae ST258 evolves via diverse mutations that Culminate in impaired adsorption. mBio. 2020;11(1). doi: 10.1128/mBio.02530-19